Are you an EP Fellow and would like to participate in the 4th TogetherVT meeting 🇳🇱?
Send us your clinical case for the chance of a live presentation in front of an expert pannel and free registration!
Deadline 30/4/24 12:00 CET
Details 👉https://t.co/uqxFY93Dbx
Are you an EP Fellow and would like to participate in the 4th TogetherVT meeting 🇳🇱?
Send us your clinical case for the chance of a live presentation in front of an expert pannel and free registration!
Deadline 30/4/24 12:00 CET
Details 👉https://t.co/uqxFY93Dbx
We are pleased to invite the EP community to the 4th edition of the togetherVT Symposium in LUMC, Leiden NL 🇳🇱 the 14th and 15th of June.
Join us for latest updates on VT management, live cases, scientific discussion & more 🫀
👉https://t.co/klsnzFZtks
#EPeeps! Ready to be a leader in EP/CIED? Dive into Level 3 of #EHRA_ESC's educational pathway! Immerse yourself in leadership and cutting-edge tech. Open to EHRA_ESC members with EP or CIED certification.
Apply by May 6th for the next #DASCAM!
https://t.co/JmvhkymNU9
@drjohnm It may lead to more cynicism that the „good“ study in this example was turned partly-positive @ESCHotline2021 by presenting an as-treated subgroup analysis; despite the „negative“ study result and the increase in strokes and death. #stopandthink#CardioTwitter
"Troponin Release after Pulmonary Vein Isolation using Pulsed Field Ablation compared to Radiofrequency and Cryoballoon Ablation" by Philipp Krisai et al had been accepted for publication by Heart Rhythm.
Great chance for Speed-Mentoring, which is an integral part of career development.🤓
Do not miss this opportunity to pick the local legends’ brain🧠🦸♀️🦸♂️🧞♀️🧞♂️
@SwissCardio @CotSwiss #cardiotwitter@NScharli@RoxanaB92172974@ASaguner @Julia_HermesL
Hightlights of the last day of the congress includes clinical electrophysiology (10:30) presentations. And at 15:30, „a bouquet of rhymology cases“ ends the case-presentations. Watch and discuss live @SwissCardio
Susanne Anna Schlossbauer presents 'Mitral valve clipping with MitraClip as therapeutic option in patients with symptomatic hypertrophic obstructive cardiomyopathy despite maximal pharmacological therapy' in #SwissCardio 2020. watch at: https://t.co/dbMQbE1Qbk